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INTERAKSI ISONIAZID DENGAN PROTEIN PEMBAWA ENOIL-ASIL 
REDUKTASE (INHA) MYCOBACTERIUM TUBERCULOSIS:  
DARI PERSPEKTIF MOLEKUL 
 
ABSTRAK 
 
Masalah kerintangan ubat dan peningkatan kes-kes tibi yang berterusan telah menggalakkan 
penyelidikan pembangunan ubat baru dan meningkatkan pemahaman mekanisme 
kerintangan ubat. Pendokkan dan simulasi dinamik molekul telah dijalankan untuk mengkaji 
aktiviti pengikatan isoniazid (INH; ubat terutama tibi) pada tapak aktif protein pembawa 
enoil-asil reduktase (InhA) Mycobacterium tuberculosis untuk meningkatkan pemahaman 
mekanisme tindakan and kerintangan INH terhadap bakteria ini. Hasil kajian menyokong 
teori yang pengaktifan INH kepada isonikotinik-asil-NADH (INADH) oleh enzim KatG 
menyumbang terhadap aktiviti terbaiknya. INADH didapati mempunyai tarikan kuat 
terhadap InhA dengan pembentukan lebih banyak ikatan hidrogen, interaksi-interaksi 
hidrofobik, elektrostatik, pi-pi dan daya van der Waals berbanding ubat induk (INH). Mutasi 
S94A pada InhA menyebabkan INADH berbeza daripada konformasi hablurnya akibat 
daripada kurang interaksi antara bahagian berkutub pada NADH dengan Ala94 yang 
hidrofobik. Disebabkan oleh kehidrofobikan dan pengurangan isipadu rantai sisi asid amino 
(S94A, I16T, I21T, I21V, I47T, V78A and I95P) pada InhA mutan (MT InhA), maka 
INADH dan MT InhA terpaksa mengaturkan semula struktur mereka supaya dapat 
menyesuai dan menstabilkan kesan sterik dan elektrostatik. Akan tetapi perubahan atomik 
yang lebih besar dan ketidakstabilan struktur pada MT InhA berbanding dengan InhA liar 
(WT InhA) tidak ketara, maka hanya kekuatan ikatan dengan INADH pada MT InhA hanya 
dikurangkan sedikit. Gly14, Ile15 dan Ala22 didapati kerap menjana ikatan hidrogen dengan 
INADH atau molekul air semasa simulasi dinamik molekul mencadangkan bahawa asid-asid 
amino ini mungkin penting dalam pengikatan INADH. Bagi jenis M. tuberculosis dengan 
S94A MT InhA yang rintang terhadap INH, INH12 and INH17 daripada terbitan INH adalah 
alternatif yang lebih baik kerana tenaga pengikatan bebas mereka lebih rendah daripada INH. 
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Kajian ini telah membuktikan teknik permodelan molekul adalah cara yang dapat 
digunapakai dalam menyelidik sifat-sifat pengikatan antara molekul penerima dan receptor 
pada peringkat molekul sebab ia berupaya menjana semula data-data eksperimen. 
Pendekatan pemodelan molekul juga merupakan cara yang berguna untuk mengkaji sesuatu 
molekul novel dengan sasarannya, khasnya jika tiada maklumat eksperimen mengenai cara 
pengikatannya.  
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INTERACTION OF ISONIAZID WITH MYCOBACTERIUM TUBERCULOSIS 
ENOYL-ACYL CARRIER PROTEIN REDUCTASE (INHA):  
FROM MOLECULAR PERSPECTIVES 
 
ABSTRACT 
 
The problem of tuberculosis (TB) drug resistance and the continuing rise in the disease 
incidence has prompted the research on new drug development as well as on increasing the 
understanding of the mechanisms of drug resistance. Molecular docking and molecular 
dynamics (MD) simulations were performed to study the binding activity of isoniazid (INH; 
a first line anti-TB drug) onto the active site of Mycobacterium tuberculosis enoyl-acyl 
carrier protein reductase (InhA) in an effort to increase the understanding of the action and 
resistance of INH in this bacteria. The results support the theory that the activation of INH to 
isonicotinic acyl-NADH (INADH) by KatG enzyme is required for its ultimate activity. It is 
shown that INADH has tremendously high binding affinity towards InhA by forming more 
hydrogen bonds, hydrophobic, van der Waals, electrostatic and pi-pi interactions, compared to 
the parent drug (INH). S94A mutation of InhA causes INADH to deviate from its crystal 
structure probably due to the poor contact between its highly polar moiety of NADH region 
with the hydrophobic Ala94. It was found that due to the hydrophobicity and reduction in 
side chain volume of mutated residue (S94A, I16T, I21T, I21V, I47T, V78A and I95P) in 
mutant type (MT) InhA, INADH and MT InhA have to rearrange their structures in order to 
accommodate and stabilize the steric and electrostatic effects. However, the greater atomic 
fluctuation and structural instabilities by INADH-MT InhA compared with that of INADH-
wild type (WT) InhA is not prominent, thus, resulted only slightly lower affinity of INADH 
in MT InhA. Gly14, Ile15 and Ala22 emerged quite frequent in forming hydrogen bonding 
with INADH or water molecules during MD simulations suggested that these molecules 
might be an essential part in INADH binding. In INH-resistant strains of M. tuberculosis 
with S94A MT InhA, derivatives INH12 and INH17 are better alternatives to INH as 
calculated binding free energy were more negative than INH. These studies show that 
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molecular modelling is a reliable method to investigate the binding properties of an acceptor 
and a receptor at the molecular level as it can reliably reproduce experimental data. The 
molecular modelling approach is also useful for exploring novel compound classes directed 
against a given target, especially when the experimental information about the binding mode 
is not available. 
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CHAPTER ONE 
GENERAL OVERVIEW 
 
1.1 Statement of the problem 
The continuing rise in tuberculosis (TB) incidence especially in the present of 
human immunodeficiency virus (HIV) infection and the problem of drug resistance strains 
towards isoniazid (a first line anti-TB drug; also known as isonicotic acid hydrazide; INH; 
Figure 1.1) have prompted the research on new drug candidates and targets, as well as the 
mechanism of drug resistance (Styblo, 1991; Kirschner, 1999; Smith & Sacchettini, 2003; 
Oliveira et al., 2006; Wells et al., 2007). Thus, the objective of this study is to utilise 
molecular docking and molecular dynamics (MD) simulations to investigate the binding of 
INH onto the active site of Mycobacterium tuberculosis enoyl-acyl carrier protein (ACP) 
reductase (InhA) in an attempt to address the mycobacterial resistance against INH.  
 
 
 
N
N
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Figure 1.1  Chemical structure of INH (C6N3OH7). Drawing tool: ACD/ChemSketch 
Freeware (http://www.acdlabs.com). 
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 The formulation of a good drug candidate is much depend on the interaction of the 
candidate with its target enzyme, therefore there is an urgent need to elucidate the 
mechanism of INH resistance in InhA mutants at molecular level. So far, experimental 
studies (Dessen et al., 1995; Rozwarski et al., 1998, 1999; Oliveira et al., 2006) were unable 
to address the resistance mechanism of INH with its target enzyme, InhA. Computational 
studies (Chen et al., 2001; Pantano et al., 2002; Schroeder et al., 2005) on the resistance 
mechanism of INH were looking at interaction between the cofactor, oxidised form of 
nicotinamide adenine dinucleotide (NADH), with InhA. There were none that examine the 
mechanism of resistance of INH itself towards InhA mutants. Thus, the present study will 
allow the insights of molecular event that leads to INH resistant to be explored. This study 
also models the interaction between INH derivatives and InhA which indeed might lead to 
some clues for the strategies of new drug development. 
 
1.2 Tuberculosis (TB) 
TB is a microbial disease, commonly infect the human lower respiratory system, 
which has affected humans for several millennia (Tortora et al., 1995). M. tuberculosis, 
which was isolated 125 years ago by Koch (Koch, 1882; cited from Youmans, 1979), is the 
aetiological agent of TB. However, this ancient scourge still remains as a major pathogen of 
human and a global tragedy with enormous public health and economic implications despite 
the advances in the prevention and treatment of the disease that it brings. Migliori et al. 
(2007) reported that World Health Organisation (WHO) identifies a need of US$47 billion to 
implement countrywide programmes to stop TB while another US$9 billion for the research 
and development of new diagnostics and treatments for TB. 
 
TB accounts for 7% of all deaths in developing countries and 26% of avoidable adult 
deaths worldwide (Gomez & McKinney, 2004). Of all the infectious bacteria, it is currently 
the leading killer of adults in the world, with an estimated 3 million people dying from TB 
every year (Stokes & Doxsee, 1999; Morgan et al., 2003). Manca et al. (1997) also reported 
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that WHO has estimated a staggering 8 million new cases globally and has projected about 
30 million deaths from TB in this decade.  
 
For over the past 10 years, there has been a steady increase notification of TB in 
Malaysia. A shocking 15,057 cases of TB was reported where the incidence rate is 64.7 per 
100,000 populations in year 2000. The number of both TB and HIV co-infections has also 
escalated from 6 cases in 1990 to 734 cases in 2000. Most patients with TB-HIV co-
infections are seen with advanced TB, thus the number of deaths due to TB-HIV has also 
increased. The worries are further compounded by the fast growing numbers of immigrant 
workers from high TB burden neighbouring countries which might add to the problem of 
multi-drug resistant TB (Iyawoo, 2004). 
 
Since 1952, INH is the frontline drug for the treatment of TB (Middlebrook, 1952). 
However its use has been restricted by as much as 30% increase of INH resistant strains 
(Miesel et al., 1998). The problem has further been complicated by the increase of multi 
drug resistant M. tuberculosis strains especially amongst HIV infected individuals 
(Eltringham et al., 1999; Rodríguez et al., 2002; Wells et al., 2007). A significant number of 
non-TB mycobacteria have been isolated from acquired immune deficiency syndrome 
(AIDS) patients (Srivastava et al., 1997). Such opportunistic mycobacteria include the 
member of Mycobacterium avium complex (MAC) caused the prevalent “TB-like” infection 
in the AIDS patients. These pathogens are generally intrinsically resistant to INH (Milano et 
al., 1996; Espinal, 2004). The survival rates of AIDS patients with MAC infection are much 
lower if compared to those who are not infected (Musser, 1995; Pratt, 2007). 
 
The above statements have prompted the search for alternatives to INH. However, in 
order to develop strategies for the design of novel and potent drugs against M. tuberculosis, 
the understanding of drug-receptor interactions is required. Thus, there is an urgent need to 
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understand resistance development at the molecular level, which until today remains an 
enigma.  
 
1.3 The importance of molecular modelling in TB research 
Today, the effectiveness of TB treatment, prevention and control programs have 
been complicated by the rise of multi-drug resistant strains and the limitation number of 
efficacious therapeutic agents to treat patients infected with MAC. The continuing 
worldwide threat of TB emphasises the urgent need of more effective diagnosis therapies, 
which is currently at a very slow process (Musser, 1995; Bardou et al., 1996; Biava et al., 
2004) due to the lack of detailed structural features regarding the drug-receptor interactions. 
Therefore, the understanding and insights of the molecular events that lead to drug action or 
resistant in M. tuberculosis are important to facilitate the rational development and 
improvement of anti-TB medications (Musser, 1995; Rouse et al., 1995; Torres et al., 2000; 
Biava et al., 2004).  
 
Drug design mostly depends on the pharmacophore hypotheses which derived from 
those inhibitors with known structures (Carlson et al., 1999, 2000; Masukawa et al., 2000). 
Although these hypotheses were able to discover some new inhibitors, the pharmacophore 
model did not provide the details of the drug-receptor interactions. Therefore, molecular 
modelling method can predict the binding modes of INH as well as its derivatives onto InhA. 
With the understanding of binding modes at the molecular level between INH and InhA, the 
search for lead/potential inhibitor(s) and the strategies for the design of new anti-TB 
compounds can be formulated. 
 
With impressive improvements in the accuracy and speed of molecular docking, 
acceptor-receptor binding mode predictions have led to a faster discoveries of new lead 
compounds. However, there are still many difficulties to overcome (Carlson & McCammon, 
2000). First, the binding modes accuracy relies on the correct estimation of acceptor-receptor 
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interaction energies and scoring functions which are simplified for computational efficiency 
(Totrov & Abagyan, 1994; Zacharias et al., 1994). Second, the sampling of acceptor in 
flexible binding pocket has not been achieved (Rosenfeld et al., 1995; Carlson & 
McCammon, 2000). Third, the involvement of solvent molecules is yet to be addressed in 
molecular docking method (Ota & Agard, 2001). Fourth, the molecular docking method is 
not able to provide the dynamics data of acceptor within the receptor binding site as the 
acceptor might be more mobile in the bound state (Ota et al., 1999).  
 
Therefore, MD simulation is also another alternative to elucidate a more refined and 
complete understanding of the binding properties of INH within the InhA binding pocket. 
MD simulation technique is time consuming and expensive (regarding large computational 
storage compared to molecular docking method). However, MD simulation is able to provide 
detailed insights of intermolecular relationships as well as the dynamics of INH-InhA 
complex. MD simulation also able to tackle the docking problems mentioned above, as it 
uses more accurate force field (an all atom approach instead of the united atom method in 
molecular docking simulation). In most cases, water molecules play a critical role in 
determining the conformation of an acceptor in a binding pocket by mediating interactions 
with the protein (Levitt & Park, 1993; Ota et al., 1999). Therefore, unlike molecular 
docking, MD simulation allows the involvement of explicit waters (instead of the simplified 
solvation parameter used in docking simulation). Finally, MD simulation methodology will 
also permit flexibility of both INH and InhA where their flexibilities might be critical for 
recognition between INH and InhA (Nagai & Mattaj, 1994; Janin, 1995; Westhof, 1997). 
 
1.4 Molecular modelling  
Advances in molecular biology, x-ray crystallography and nuclear magnetic 
resonance (NMR) spectroscopy have led to high resolution at the molecular level of three 
dimensional structures for a numerous proteins (Lambert, 1997). However, not all proteins 
are easy to be crystallized (Peters & Pinto, 1996), while NMR experiment does not give 
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complete atomic structures but only overviews for proteins with amino acids beyond the 
number of 200 residues (Campbell, 1995; Asensio et al., 2000). Therefore, computer-based 
molecular modelling techniques such as molecular docking and MD simulation are 
obviously attractive methods to predict and derive a molecular insight of the acceptor-protein 
complex structure (Hetĕnyi & van der Spoel, 2002).  
 
Molecular modelling is a term used to describe the study of molecules and molecular 
systems. It is also a technique to investigate and predict chemical entities and processes 
using theoretical methods. This technique has been used in many fields such as chemistry, 
biology, or materials science to study systems ranging from small chemical molecules to 
large biological molecules and material assemblies. Molecular modelling is able to give 
information at the atomistic level description of the studied systems. The simplest system 
can be performed by hand using theoretical calculations, but inevitably computers are 
required to study reasonably sized systems. Today’s molecular modelling is also known as 
computational chemistry as it is invariably associated with computer modelling. Advances in 
speed and memory availability of computational power have allowed broader range of 
models and up to millions of atoms to be included in the calculation (Leach, 1996). 
 
In general, computer-based molecular modelling simulates the chemical structures 
and reactions numerically based on the fundamental laws of physics. This method allows 
researchers to study chemical phenomena by running calculations instead of wet-lab 
experiment. Some simulations can be used to model not only stable molecules, but also 
unstable intermediates and transition states of chemical structures and reactions. In this way, 
these theoretical methods can provide information about molecules and reactions, which is 
almost impossible to observe through wet-lab experiment. Therefore, molecular modelling is 
an independent research area which could be vital adjunct and alternative to experimental 
studies (Foresman & Frisch, 1993). 
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1.5 The fundamental of molecular modelling 
1.5.1 Energy minimization 
In real life, molecules vibrate around their equilibrium structures with minimum 
energy. The change of energy can be regarded as movements on a three dimensional energy 
surface. At a minimum point, the forces on all atoms are zero and correspond to stable 
structures and any movement away from the minimum will give a higher energy structure. 
Figure 1.2 shows an energy surface and the minimum that would be gained by starting from 
point X, Y and Z. The minimum is corresponding to the positions where a ball rolling down 
the energy surface with the gravity influences and come to a stop. Global energy minimum is 
the minimum with the lowest energy. Minimization algorithm is thus, a method in the 
calculation and identification of the geometries of a system that correspond to minimum 
points on the energy surface (Cramer, 2002). 
 
Energy minimization is an integral part of molecular modelling techniques. It is 
recommended to be part of the protocol for the simulation of complex systems such as 
macromolecules or large molecular assemblies, e.g. drug-protein complex in order to relieve 
any unfavourable interactions and stereo overlaps in the starting configuration of a system. 
For example, during a molecular simulation, the missing hydrogen atoms are usually added 
based on the geometry specified in the residue database and may not correspond to the actual 
minimum in the force field. Thus, the placement does not consider any conflicts, electrostatic 
inconsistencies or overlaps with other atoms or residues. Large stereo overlaps will lead to 
large forces initially, which will also form large velocities and may cause the distortion of 
the structure or system. For this reason, prior to simulation, it is necessary to minimise the 
initial system, thus the energy.  
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Figure 1.2 A schematic one-dimensional energy surface. Minimization methods move 
downhill to the nearest minimum. 
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1.5.1.1 Minimization algorithms 
Minimization algorithms are classified into two types: those that use derivatives of 
energy with respect to the coordinates and those that do not. The choice of minimization 
algorithm depends on a number of factors. These include the speed and storage of the 
workstation, the availability of analytical derivatives and the robustness of the algorithm. 
Calculations on systems containing thousands of atoms such as biological systems usually 
use the first derivative minimization methods, e.g. steepest descents method and conjugate 
gradients minimization. 
 
Steepest descents method moves to the minimum force in a parallel direction, which 
corresponds to walking straight down hill in the geographical analogy (Figure 1.3). The 
direction of this method is determined by the highest inter-atomic forces and thus, it is a 
good method to relieve the initial highest energy features. However, steepest descents 
method faces the problem of too many small steps have to be performed when going down a 
long narrow valley and, might oscillate and continuously over-correct itself (Cramer, 2002). 
 
The conjugate gradients method provides directions which do not show the steepest 
descents oscillatory behaviour in narrow valleys. In this method, the gradients at each point 
are orthogonal but the directions are “conjugated” (Figure 1.4). It is less superior to steepest 
descents method when the initial starting configuration is still too far from the minimum 
(Leach, 1996).  
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Figure 1.3 The steepest descents method in the search of minimum energy. 
 
 
 
Figure 1.4 The conjugate gradients minimisation in the search of minimum energy. 
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It is believed that the best way of minimization is to relieve the initial stress of a 
system by the steepest descents prior to the conjugate gradients. Specifically, in a system 
with large number of atoms, frequently two stages of minimization will be used. In order to 
get a structure without significant high-energy interactions, the steepest descents method will 
be used as a first stage of minimization. Conjugate gradients minimization will be the second 
stage minimization after the steepest descents method to give the structure closer to the 
minimum energy. However, too few steps of minimization will lead to instabilities while too 
many minimization steps will over minimized and modified the model away from the control 
structure (the x-ray crystallography structure). Thus, the complete structure of a system is 
best to be minimized briefly with respect to the atomic coordinates, usually with a mix of 
both steepest descend and conjugate gradient methods (e.g. 1000 steps for each method) 
without any constrains on the atoms (Beck & Daggett, 2004). 
 
1.5.2 Molecular mechanics force field 
The potential energy in a relatively large system such as biological system is derived 
using molecular mechanics (MM; also known as empirical force field method or force field 
method) method. A force field has three components (Foresman & Frisch, 1993): 
a. A set of equations to define how the potential energy of an atom varies with the 
position. 
b.  A series of atom types to define the characteristics of the elements. The atom types 
prescribe different characteristic depending on the environment, and depend on 
hybridisation, charge and the types of other atoms to which an atom is bonded. For 
example, a carbon atom in carbonyl group is treated differently than the one bonded to 
a methyl group. 
c. Parameter sets that fit the equations and atom types to experimental data. The 
parameter sets define force constant values used in the equations to relate atomic 
characteristics to energy components, and structural data (such as bond lengths and 
angles). 
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In MM, electrons effects in a system are implicitly included in the force fields via its 
parameterisation. This approximation makes MM computationally relatively inexpensive and 
allows the used of large systems containing millions of atoms, but it carries some limitations 
(Foresman & Frisch, 1993): 
a. Certain force fields achieve good results only for a particular class of molecules which 
have been parameterised. No force field can be generally used for all molecular 
systems. 
b. Implicit treatment of electrons means that MM cannot simulate chemical problems 
where electronic effects predominate. For example, bond formation or bond breaking, 
or proton transfer, or predict molecular properties which depend on molecular orbital 
interaction, cannot be described. 
 
In a molecular system, the intra-molecular forces, generated by the bonded 
interaction are contributed by bond stretching, angle bending and bond torsions. While the 
inter-molecular forces, generated by the non-bonded interaction, include van der Waals and 
electrostatic interactions (Figure 1.5). Equation 1.1 generally represents the MM force field. 
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Figure 1.5 Schematic representations of the key contributors to a molecular mechanics 
force field: bond stretching, angle bending and torsional terms as bonded 
interactions while van der Waals and electrostatic forces as non-bonded 
interactions. 
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E (rN) denotes the potential energy with the function of the positions (r) of N atoms. The first 
to the fourth terms are the bonded terms while the fifth and the sixth terms are the non-
bonded terms. This potential energy function is the summation of all the bonded (i.e. bond, 
angle, torsion and improper torsion energies) and the non-bonded terms (i.e. van der Waals 
and electrostatic interactions). 
 
The first term in Equation 1.1 calculates the interaction between pairs of bonded 
atoms using harmonic potential (Hooke’s law) that will increase in energy as the bond length 
li deviates from the reference value li,0; kℓ is the force constant. The second term summates 
all valence angles in the molecule, also modelled using Hooke's law (the valence angle, θi, is 
the angle between atom A, B and C, which A and C are both bonded to B, to a reference 
value θ0); kθ is the force constant. The third term is to model torsional potential and to 
calculate the energy changes when a torsional bond rotates; kn is the force constant, n is the 
multiplicity (the number of minimum points when the bond is rotated through 360º), ω is the 
torsion angle, γ is the phase factor (determines the torsion angle that passes through its 
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minimum). The kτ in improper torsion potential, the fourth term, is the force constant and ω 
is the improper dihedral angle.  
 
The last two terms (the fifth and the sixth terms) are the calculation between pairs of 
atoms (atom i and atom j) that are in different molecules, or in the same molecule but are 
separated by at least three bonds. The fifth term models the van der Waals interactions using 
Lennard-Jones (LJ) 12-6 potential, where εij is the dispersion well depth, σij is the LJ distance 
and r is the distance. The last term models the electrostatic interactions using Coulomb 
potential, where qi and qj are the atomic partial charges for atom i and atom j, ε is the 
dielectric constant, rij is the distance between atom i and atom j (Figure 1.6).  
 
Electrostatic interaction energy calculation can be improved by Particle Mesh Ewald 
(PME) method. This method is for fast implementation of Ewald summation with B-splines 
interpolation to calculate the electrostatic energy of a given unit cell in a macroscopic lattice 
consists of repeating images for a better analytic gradients and accuracy (Essmann et al., 
1995). PME method in Assisted Model Building and Energy Refinement (AMBER) 
simulation package, which is used in this study for MD simulation, not only provides a better 
treatment of long-range electrostatics at a modest computational cost, but can also be applied 
in periodic boundary simulation (see below).  
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Figure 1.6  The Lennard-Jones (LJ) potential. V(r) is the pairwise potential energy; r is 
the internuclear separation in between two non-bonded atom; reqm is the 
equilibrium internuclear separation; ε is the well depth at reqm. 
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1.5.3 Principles of MD simulations 
MD simulation is the science of simulating the motions of particles in a system and 
gives the fluctuation in the relative positions of atoms as a function of time (Karplus & 
Petsko, 1990). In other words, MD simulation is a method/technique of studying time 
evolution of the atomic degrees of freedom by solving the Newtonian equations of motion 
numerically (Allen & Tidesley, 1987). However, MD cannot be solved simultaneously. 
Thus, numerical methods are applied to calculate the dynamics of the system. A large 
number of MD programs have been developed to provide an insight of the dynamics of 
molecules, for example, ENCAD (Levitt et al., 1995), GROMOS96 (van Gunsteren et al., 
1996), Q (Marelius et al., 1998c), MAXIMOBY (Jödicke et al., 2001) and AMBER (Case et 
al., 2004). 
 
  In MD, integrating Newton’s law of motion will generate successive configurations 
of a system and give the trajectory that specifies how the positions and velocities of the 
particles in the system vary with time. These trajectories and the motions of the system are 
obtained by solving the equation embodied in Newton’s second law (Equation 1.2). 
Fi = miai       ….. 1.2 
The forces exerted on the atoms, Fi, is determined by the masses, mi, and the accelerations, ai 
of the system with i atoms. The forces acting on the atoms can be obtained from the 
derivatives of the potential energy function, U, with respect to the atoms positions, ri 
(Equation 1.3).  
idr
dU
 = Fi       ….. 1.3 
The accelerations of the atoms (ai) can be determined (Equation 1.4). 
 ai = 
i
i
m
F
       ….. 1.4 
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Thus, the changes in atoms velocities and positions can be calculated with the knowledge of 
the accelerations of all atoms and the trajectories of the atoms as a function of time can be 
obtained. 
 
 Equation 1.5 is the Verlet algorithm (Verlet, 1967) for the atomic trajectories 
integration in MD simulation. The atoms new positions at t + δt, ri(t + δt) can be calculated 
from the previous step, ri(t – δt), uses the positions (ri) and accelerations (ai) at time. 
  ri(t + δt) = 2ri(t) - ri(t - δt) + δt2ai(t)    ….. 1.5 
 
Thus, the velocities (vi) can be calculated similarly by dividing the difference in positions at 
time t + δt and t - δt by 2δt (Equation 1.6). 
 
  vi (t) = [ri(t + δt) - ri (t - δt)]/2δt     ….. 1.6 
 
The leap-frog algorithm from Hockney (1970) is a variation of Verlet algorithm. It is used in 
AMBER, a program that is used throughout this study. Other methods to integrate the 
equation include the predictor-corrector methods (Gear, 1971), Beeman’s algorithm 
(Beeman, 1976) and velocity Verlet method (Swope et al., 1982). 
 
1.5.3.1 MD simulation ensembles 
 Traditionally, MD is performed with the microcanonical ensembles (NVE)- constant 
number of atoms, volume and energy; canonical ensembles (NVT)- constant number of 
atoms, volume and temperature; or isothermal-isobaric ensembles (NPT)- constant number 
of atoms, pressure and temperature (Mihailescu & Smith, 2000). Most experimental 
measurements are made under the conditions of constant temperature and pressure, thus 
simulations in NPT ensembles, which is used in this study, are most directly relevant to 
experimental data.     
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1.5.3.2 Boundaries and cutoff 
Computer simulation enables the calculation of macroscopic properties using 
relatively small numbers of particles. Thus, the boundaries and boundary effects are crucial 
and have to be treated carefully in any MD simulation. The periodic boundary conditions 
application will enable the simulation of a relatively small number of particles to experience 
the forces as if they are in bulk fluid. In a two-dimensional example, each box is surrounded 
by eight image neighbours (Figure 1.7); thus, in three-dimensions, each box will be 
surrounded by 26 image neighbours. Should a particle leave the box during the simulation, it 
will be replaced by an image particle from its image neighbour (Essmann & Darden, 1997). 
 
In MD simulation, the number of bonded terms in a force field is proportional to the 
number of atoms (N) but the number of non-bonded terms increases as the square of the 
number of atoms (N2). Thus, minimum image convention and non-bonded cutoff are applied 
to handle this time consuming calculation. In minimum image convention, each atom only 
sees one image of every other atom at the most in the system (which the system is repeated 
via periodic boundary conditions for macroscopic effects). The non-bonded energy is thus 
calculated with the closest atom (Figure 1.8).  
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Figure 1.7 A two dimensional periodic boundary conditions. 
 
 
Figure 1.8 The minimum image convention and spherical cutoff (circle). 
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While in non-bonded cutoff, the interactions between all pairs of atoms among the 
closest image will be considered, but those further away from the cutoff value will be set to 
zero. However, during the application of periodic boundary conditions, the cutoff should not 
be so large until the particle sees its own image or the same molecule twice. Therefore, the 
cutoff is limited to less than half the length of the cell (Essmann & Darden, 1997). A very 
short cutoff (4 Å) usually will not adequately model the electrostatic properties of a system. 
Therefore, slightly longer cutoff ranges (such as 8 and 10 Å) have been shown to behave 
quite similar to much longer cutoff such as 12, 14 and 16 Å (Levitt et al., 1995; Levitt et al., 
1997; Beck et al., 2005). 
 
1.5.3.3 Free energy calculation in MD simulation 
Binding affinity calculation for an acceptor based on MD simulation provides an 
important and useful link between the structure and function of a biomolecular system. 
Therefore, characterizing the structures and energetics of molecular complexes are the keys 
for the understanding of many biological systems/functions (Ajay et al., 1997; Marelius et 
al., 1998c; Åqvist & Marelius, 2001; Åqvist et al., 2002). Computational methods that could 
be used for molecular complexes binding affinity calculations including empirical scoring 
method (Böhm, 1992, 1998; Wang et al., 1998b; Wang et al., 2002b), free energy 
perturbation (FEP) approach (Beveridge & DiCapua, 1989; Kollman, 1993; Kollman et al., 
2000) and linear interactions energy (LIE) method (Åqvist et al., 1994, 2002; Jones-Hertzog 
& Jorgensen; 1997; Hansson et al., 1998; Åqvist & Marelius, 2001).  
 
In empirical scoring method, the accuracy is limited due to the simplicity of the 
scoring function. Water molecules are usually not considered, which could be a problem 
especially in biological complexes as these water molecules are an integral part of the 
system, e.g. bridging interactions between the acceptor and the receptor. FEP method is a 
more accurate method for the acceptor-receptor binding free energy calculation. It provides a 
rigorous way of free energies and pair-wise interactions evaluation, but it is however 
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computationally expensive and time consuming (Åqvist & Marelius, 2001; Asi et al., 2004). 
Between the two extremes of empirical scoring functions and FEP methods, LIE method 
(based on the estimation of force field energy from acceptor-receptor interactions and 
thermal conformational sampling) has emerged as a useful method to calculate the binding 
free energy from MD simulation. LIE approach has the advantages of a) the thermal 
averaging over conformations could be calculated, b) in contrast to FEP method, it does not 
require the transformation process involving unphysical states, c) it is based on estimating 
the absolute binding energies, and d) it is slower than scoring of single conformations, but it 
is faster than FEP calculations (Hansson et al., 1998). 
 
 In the present study, the ligand free energy of binding from MD simulation is 
calculated using LIE method. This method is based on the evaluation of ligand interaction 
energies in both bound (complex with receptor) and free states (without receptor). The idea 
deriving from LIE method is that only averages of the interaction energies between the 
ligand and its surroundings need to be evaluated. Thus, accordingly, two MD simulations 
have to be carried out, one with the ligand free in solution and one where it is bound to 
solvated receptor. The binding free energy (∆Gbind) is thus, obtained from the averages 
(Equation 1.7). 
  ∆Gbind  =  α ( 〈V LJsl− 〉 bound - 〈 V LJsl− 〉 free) 
                          +   β ( 〈V el sl− 〉 bound - 〈 V el sl− 〉 free)   ….. 1.7 
The α is scaling factor for LJ interaction energy and β is scaling factor for electrostatics 
interaction energy. The 〈 V LJsl− 〉 bound denotes LJ interaction energy between the bound ligand 
and its surrounding environment (e.g. water molecules, protein atoms and ions) 
and 〈V LJsl− 〉 free is LJ interaction energy between free-state ligand and its surrounding 
environment. The 〈V el sl− 〉 bound denotes electrostatic interaction energy between the bound 
ligand and its surrounding environment (e.g. water molecules, protein atoms and ions) and 
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〈V el sl− 〉 free is electrostatic interaction energy between free-state ligand and its surrounding 
environment. 
 
 Åqvist and Hansson (1996) observed that the β value varies with the number of 
hydroxyl groups in a ligand (compounds with higher number of hydroxyl groups are 
associated with lower values of β). These considerations have led Hansson et al. (1998) to a 
model where the chemical group deviations for each ligand were taken into account. They 
divided ligand into four groups: a) charged, b) dipolar with no hydroxyl, c) dipolar with one 
hydroxyl and, d) dipolar with two or more hydroxyl, and assigned different electrostatic 
coefficient β parameter value to each group. These values of β (0.50, 0.43, 0.37 and 0.33, 
respectively) were obtained from the simulations of compounds from different groups. Same 
β values were used for both bound and free states for the same compound. The results 
obtained with the set of FEP-derived model yielded a good agreement with experimental 
values for the 18 complexes in the calibrations set. The α value (0.181) was also obtained 
from the same simulations. Thus, Hansson et al. (1998) summarized that an optimal equation 
for binding free energy calculation can be obtained with only one free parameter, while  β 
depends on the class/group of ligand. 
 
1.5.4 Molecular docking 
Generally, biologically active molecules exert their effect by binding to a target or 
receptor. The ability of a “ligand” or “acceptor” to interact with a “target” or “receptor” is 
determined by the functional group(s) and the three-dimensional (3D) features (DesJarlais, 
1997). A detailed understanding of the interactions between ligands and their receptors is 
essential for interpreting many biochemical phenomena (Sotriffer et al., 2000a). “Ligand” 
comes from “ligare” (Latin) meaning a “band” or “tie”. It is used to define a molecule of any 
size that interacts with another molecule through non-covalent forces which does not involve 
any formation of covalent bond. The “target” or “receptor” - is typically larger molecule 
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(macromolecule e.g. enzyme or protein). The interaction between a ligand and receptor 
depends on the chemical or physical forces on each of them, between them and also their 
environment (Krumrine et al., 2003). 
 
The interactions between a ligand and a receptor have been widely investigated 
using molecular modelling techniques reviewed by Taylor et al. (2002). Hetĕnyi and van der 
Spoel (2002) have listed steps for successful prediction of a ligand-target complex: a) the 
definition of the protein structure, b) the location of binding site, and c) the determination of 
the binding mode. Molecular docking is one of the extensively used molecular modelling 
techniques to predict the conformation of ligand-receptor complex. It is a method that seeks 
to find ways of fitting two molecules together in the favourable configuration and suggest 
the binding modes of the complex. A large numbers of docking programs have been 
developed, e.g. DOCK (Shoichet & Kuntz, 1993), GOLD (Jones et al., 1995, 1997), FlexX 
(Rarey et al., 1996), AutoDock (Morris et al., 1996) and EUDOCK (Pang et al., 2001).  
 
The docking programs provide an automated procedure to predict the interaction of 
ligand with its receptor, fall into two broad categories: matching and docking simulated 
methods (Goodsell & Olson, 1990). The matching method creates a model of the active site 
from the receptor and attempts to dock the ligand into the modelled site as a rigid body by 
matching the ligand’s geometry to that of the modelled active site and it is efficient to screen 
an entire chemical database rapidly for lead compounds. The second type of docking 
techniques: the docking simulated method models the docking of a ligand to a receptor in 
details where the ligand explores the translations, orientations, and conformations until an 
ideal site is found. The docking simulated technique are relatively slower than the matching 
method, but allows the flexibility of the ligand to be modelled and able to utilize detailed 
MM to calculate the energy of the ligand in complex with the active site. AutoDock that is 
used throughout this research is an example of the latter technique which allows flexible 
ligand to be docked.  
